 | • レポートコード：MRC2302C052 • 出版社/出版日：360iResearch / 2023年2月3日 • レポート形態：英語、PDF、235ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に8,607.09百万ドルであった世界の植物ゲノム市場規模が、2022年に9,378.07百万ドルに達し、2027年には年平均成長率9.13%で14,542.18百万ドルまで成長すると予測しています。当調査レポートでは、植物ゲノムの世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、目的別（DNA抽出・精製、DNA/RNA配列決定、遺伝子組換え体純度検査、遺伝子発現プロファイリング）、種類別（遺伝子工学、分子工学）、形質別（耐病性、除草剤耐性、収量向上）、作物別（穀物、果物＆野菜、油糧種子＆豆類）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、Abbott Laboratories、ACS Diagnostics、Alivecor, Inc.、Asahi Kasei Corporation、Bexen Cardio、Biotelemetry、Biotronik、Boston Scientific Corporation、BPL Medical Technologies、BTL、GE Healthcare、Hill-Rom Holdings, Inc.、Koninklijke Philips N.V.、Lepu Medical Technology、Medtronic Plc、Metrax Gmbhなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の植物ゲノム市場規模：目的別 - DNA抽出・精製における市場規模 - DNA/RNA配列決定における市場規模 - 遺伝子組換え体純度検査における市場規模 - 遺伝子発現プロファイリングにおける市場規模 ・世界の植物ゲノム市場規模：種類別 - 遺伝子工学の市場規模 - 分子工学の市場規模 ・世界の植物ゲノム市場規模：形質別 - 耐病性植物ゲノムの市場規模 - 除草剤耐性植物ゲノムの市場規模 - 収量向上植物ゲノムの市場規模 ・世界の植物ゲノム市場規模：作物別 - 穀物の市場規模 - 果物＆野菜の市場規模 - 油糧種子＆豆類の市場規模 ・世界の植物ゲノム市場規模：地域別 - 南北アメリカの植物ゲノム市場規模 アメリカの植物ゲノム市場規模 カナダの植物ゲノム市場規模 ブラジルの植物ゲノム市場規模 … - アジア太平洋の植物ゲノム市場規模 日本の植物ゲノム市場規模 中国の植物ゲノム市場規模 インドの植物ゲノム市場規模 韓国の植物ゲノム市場規模 台湾の植物ゲノム市場規模 … - ヨーロッパ/中東/アフリカの植物ゲノム市場規模 イギリスの植物ゲノム市場規模 ドイツの植物ゲノム市場規模 フランスの植物ゲノム市場規模 ロシアの植物ゲノム市場規模 … - その他地域の植物ゲノム市場規模 ・競争状況 ・企業情報 |
The Global Plant Genomics Market size was estimated at USD 8,607.09 million in 2021 and expected to reach USD 9,378.07 million in 2022, and is projected to grow at a CAGR 9.13% to reach USD 14,542.18 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Plant Genomics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Objective, the market was studied across DNA Extraction & Purification, DNA/Rna Sequencing, GMO-Trait Purity Testing, Gene Expression Profiling, Genotyping, and Marker-Assisted Selection (MAS).
Based on Type, the market was studied across Genetic Engineering and Molecular Engineering.
Based on Trait, the market was studied across Disease Resistance, Herbicide Tolerance, and Yield Improvement.
Based on Crops, the market was studied across Cereals & Grains, Fruits & Vegetables, and Oilseeds & Pulses.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Plant Genomics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Plant Genomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Plant Genomics Market, including Agilent Technologies Inc, BGI Group, Eurofins Scientific Inc, Floragenex, Inc., GENEWIZ, Genotypic Technology Pvt. Ltd., Illumina, Inc., KeyGene, LC Sciences LLC, Neogen Corporation, Novogene Co., Ltd., NRGene, Oxford Nanopore Technologies Limited, QIAGEN N.V., and TraitGenetics GmbH.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Plant Genomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Plant Genomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Plant Genomics Market?
4. What is the competitive strategic window for opportunities in the Global Plant Genomics Market?
5. What are the technology trends and regulatory frameworks in the Global Plant Genomics Market?
6. What is the market share of the leading vendors in the Global Plant Genomics Market?
7. What modes and strategic moves are considered suitable for entering the Global Plant Genomics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological advancements ensuring strong market growth
5.1.1.2. Rise in demand for improved crop varieties
5.1.1.3. Cost-effectiveness of genomics
5.1.1.4. Rise in plant genome funding fueling the adoption of innovative technologies
5.1.2. Restraints
5.1.2.1. Limited usage of automated instruments due to the high cost
5.1.2.2. High cost of infrastructure
5.1.3. Opportunities
5.1.3.1. Growth in emerging economies providing huge scope for market development
5.1.3.2. Rising opportunities for using novel DNA sequencing technologies
5.1.4. Challenges
5.1.4.1. Lack of awareness in handling modern plant genomic technologies, in developing economies
5.1.4.2. Hazardous effects of GMOs limiting research practices in plant genomics
5.2. Cumulative Impact of COVID-19
6. Plant Genomics Market, by Objective
6.1. Introduction
6.2. DNA Extraction & Purification
6.3. DNA/Rna Sequencing
6.4. GMO-Trait Purity Testing
6.5. Gene Expression Profiling
6.6. Genotyping
6.7. Marker-Assisted Selection (MAS)
7. Plant Genomics Market, by Type
7.1. Introduction
7.2. Genetic Engineering
7.3. Molecular Engineering
8. Plant Genomics Market, by Trait
8.1. Introduction
8.2. Disease Resistance
8.3. Herbicide Tolerance
8.4. Yield Improvement
9. Plant Genomics Market, by Crops
9.1. Introduction
9.2. Cereals & Grains
9.3. Fruits & Vegetables
9.4. Oilseeds & Pulses
10. Americas Plant Genomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Plant Genomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Plant Genomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies Inc
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. BGI Group
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Eurofins Scientific Inc
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Floragenex, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. GENEWIZ
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Genotypic Technology Pvt. Ltd.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Illumina, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. KeyGene
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. LC Sciences LLC
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Neogen Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Novogene Co., Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. NRGene
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Oxford Nanopore Technologies Limited
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. QIAGEN N.V.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. TraitGenetics GmbH
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
